Information for module PHAR3001
This module is available for: The current academic year
If you're a member of UCL you can add this module to your personalised course list
This information is for guidance only. If you are a UCL undergraduate interested in studying one of these courses, you must seek permission from both the providing department and your 'home' department. Appearance in this database is not a guarantee that a course is running in any particular academic year.
|Module code:||PHAR3001(Add to my personalised list)|
|Division:||Division of Biosciences|
|Module organiser:||Prof A H Dickenson|
|Available for students in Year(s):||3,|
|Module prerequisites:||2nd year Pharmacology (PHAR2003/PHAR2006 and/or PHAR2002/5) or Biomedical Sciences (Drug action stream) OR MBBS Y1&2.|
|Module outline:||In recent years many developments, such as the use of levo dopa in Parkinsonism, the manipulation of excitation in epilepsy and the discovery of endogenous opioids, have brought basic neuropharmacology and the successful treatment of disorders of the C.N.S. much closer together. It is likely that future prospects for drug therapy in neurology and psychiatry will depend very much on a better understanding of neurotransmitter function and manipulation. This neuropharmacology course tries to provide a basis for such an understanding. The evidence for different transmitters (from morphological, electrophysiological, pharmacological and biochemical studies) is evaluated so as to build up a picture of their pre- and post-synaptic actions and their interactions in specific pathways and brain areas. This knowledge is then applied to a consideration of various disease states and drug action. Special emphasis is given to neurotransmitter function and malfunction in epilepsy, Parkinsonism, memory, cell death and pain states and to the mode of action of drugs in these conditions. Students attend a comprehensive series of lectures given by experts in the field. The evaluation of published work and a proper appreciation of the problems facing research workers is helped by practical experience of the methods used. Accordingly students taking the whole unit (C3) will perform individual or group projects on the release and electrophysiological and behaviourial effects of neurotransmitters and their modification by drugs.|
|Module aims:||To understand the chemical and neural events that underlie function of the CNS in health and disease.|
|Module objectives:||Cutting edge approaches to understanding CNS function, exposure to advanced practical skills, to analyse and report on experimental evidence.|
|Key skills provided by module:|
|Module assessment:||Unseen three-hour written examination 50.00%.|
1 essay 10.00%.
4 practicals 40.00%.
|Notes:||Please note that this module is capped to accomodate a maximum of 56 students because of the practical elements involved. Priority will be given to Pharmacology students, BSc and IBSc. Other considerations that will be taken into account include second year marks, 2nd year courses taken and previous practical experience - the latter is a major element of the course. The 0.5cu PHAR3002 - Neuropharmacology sister module (without practicals) will not be capped.|
|Taking this module as an option?:|
|Link to virtual learning environment(registered students only)||http://www.ucl.ac.uk/lifesciences-faculty/degree-programmes/pharmacology/modules|
|Last updated:||2016-08-30 21:34:57 by|